Expression of CD31, Met/hepatocyte growth factor receptor and bone morphogenetic protein in bone metastasis of osteosarcoma

被引:27
|
作者
Arihiro, K
Inai, K
机构
[1] Kure Natl Hosp, Chugoku Dist Canc Ctr, Div Pathol, Dept Clin Lab, Hiroshima 7370023, Japan
[2] Hiroshima Univ, Sch Med, Dept Pathol 2, Hiroshima, Japan
关键词
bone metastasis; bone morphogenetic protein; CD31; immunohistochemistry; insulin-like growth factor receptor; Met/hepatocyte growth factor receptor; osteosarcoma;
D O I
10.1046/j.1440-1827.2001.01164.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The mechanism of metastasis of osteosarcoma cells to other bones has not yet fully been clarified. The purpose of the present study was to examine whether various factors involve the formation of osteosarcoma metastatic foci in other bones. Immunohistochemically, CD31 expression in osteosarcoma with no bone metastasis and osteosarcoma with bone metastasis was noted in 10 and 75% of cases, respectively. Met/hepatocyte growth factor (HGF) receptor expression in osteosarcoma with no bone metastasis and osteosarcoma with bone metastasis was noted in 90 and 25% of cases, respectively. Bone morphogenetic protein (BMP) expression in osteosarcoma with no bone metastasis and osteosarcoma with bone metastasis was noted in 20 and 75% of cases, respectively. Metastasis of osteosar-coma cells to other bones was significantly correlated with expression of BMP and CD31 and with no expression of Met/HGF receptor protein in osteosarcoma cells. In contrast, expression of insulin-like growth factor receptor in osteosarcoma cells did not correlate significantly with bone metastasis. These results suggest that formation of metastatic foci of osteosarcoma cells in other bones is regulated by CD31, which is associated with migration between endothelial cells, by BMP, which can induce and activate various mesenchymal cells affecting bone formation, and by escape of effect by HGF, which promotes differentiation of osteosarcoma cells.
引用
收藏
页码:100 / 106
页数:7
相关论文
共 50 条
  • [31] Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor
    Atkinson, C
    Stewart, S
    Upton, PD
    Machado, R
    Thomson, JR
    Trembath, RC
    Morrell, NW
    CIRCULATION, 2002, 105 (14) : 1672 - 1678
  • [32] Bone morphogenetic protein-2 is markedly synergistic with tumor necrosis factor in stimulating the production of nerve growth factor in fibroblasts
    Hattori, A
    Tsujimoto, M
    Hayashi, K
    Kohno, M
    BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL, 1996, 38 (06): : 1095 - 1101
  • [33] The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion
    Minamide, Akihito
    Yoshida, Munehito
    Kawakami, Mamoru
    Okada, Motohiro
    Enyo, Yoshio
    Hashizume, Hiroshi
    Boden, Scott D.
    SPINE, 2007, 32 (10) : 1067 - 1071
  • [34] Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro
    Owen, Sioned
    Sanders, Andrew J.
    Mason, Malcolm D.
    Jiang, Wen G.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (03) : 919 - 928
  • [35] RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells
    Wittrant, Y
    Lamoureux, F
    Mori, K
    Riet, A
    Kamijo, A
    Heymann, D
    Redini, F
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (01) : 261 - 269
  • [36] Receptor activator of nuclear Factor-κB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis
    Sasaki, Atsushi
    Ishikawa, Kenji
    Haraguchi, Naotsugu
    Inoue, Hiroshi
    Ishio, Tetsuya
    Shibata, Kohei
    Ohta, Masayuki
    Kitano, Seigo
    Mori, Masaki
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (03) : 1191 - 1199
  • [37] Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Expression in Hepatocellular Carcinoma With Bone Metastasis
    Atsushi Sasaki
    Kenji Ishikawa
    Naotsugu Haraguchi
    Hiroshi Inoue
    Tetsuya Ishio
    Kohei Shibata
    Masayuki Ohta
    Seigo Kitano
    Masaki Mori
    Annals of Surgical Oncology, 2007, 14 : 1191 - 1199
  • [38] Expression of Connective Tissue Growth Factor and Bone Morphogenetic Protein-7 in Pseudomonas aeruginosa-induced Chronic Obstructive Pulmonary Disease in Rats
    Wen, Wen
    Wang, Ai-min
    Liu, De-ling
    Zhang, Ya-bin
    Yao, Li-qing
    Lai, Guo-xiang
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 10 (06) : 657 - 666
  • [39] Involvement of hepatocyte growth factor in the development of bone metastasis of a mouse mammary cancer cell line, BALB/c-MC
    Ono, Katsuhiro
    Kamiya, Sadahiro
    Akatsu, Takuhiko
    Nakamura, Chika
    Li, Minqi
    Amizuka, Norio
    Matsumoto, Kunio
    Nakamura, Toshikazu
    Kugai, Nobuo
    Wada, Seiki
    BONE, 2006, 39 (01) : 27 - 34
  • [40] Bone morphogenetic protein 4 (BMP-4) and BMP-7 induce vascular endothelial growth factor expression in bovine granulosa cells
    Shimizu, Takashi
    Magata, Fumie
    Abe, Yasuyuki
    Miyamoto, Akio
    ANIMAL SCIENCE JOURNAL, 2012, 83 (09) : 663 - 667